Adherencia a la Terapia Hormonal Adyuvante con Tamoxifeno y Anastrozol utilizando ARMS-12 y MMAS-4

Autor: Botelho, Lorena Oliveira de, Sañudo, Adriana, Facina, Gil, Wagner, Gabriela Arantes

Publikováno v: Revista Brasileira de Cancerologia; Vol. 68 No. 2 (2022): Apr./May/June; e-121960
Revista Brasileira de Cancerologia; Vol. 68 Núm. 2 (2022): abr./mayo/jun.; e-121960
Revista Brasileira de Cancerologia; v. 68 n. 2 (2022): abr./maio./jun.; e-121960
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA

Introduction: Among breast cancers, approximately 75% of women are hormone receptors-positive, and these are more likely to respond to hormone therapy with anastrozole and tamoxifen. Although effective, they have significant rates of non-adherence. O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::f989f9bcd100dc8d3659f24a3de2c3db
https://rbc.inca.gov.br/index.php/revista/article/view/1960